H (2000-2009)

*older Articles in Pre-2000 List

HAIR
HEADACHE (See MIGRAINE / HEADACHE)
HEARING* (See Also TINNITUS; AM-111 in SYNTHETICS)
HEART DISEASE / CARDIOVASCULAR*
HEMORRHAGIC SHOCK*
HEMP
HEPATITIS
HEREDITARY MULTIPLE EXOTOSES
HERPES VIRUS *
HICCUPS*
HIP REPLACEMENT
HIV / AIDS*
HOMEOSTASIS (Keeping Your Body Running Like It Should Run)
HORMONES*
HPV / HUMAN PAPILLOMA VIRUS
HUNTINGTON’S DISEASE
HYPEREKPLEXIA DISEASE (See STIFF PERSON SYNDROME)
HYPEREMESIS (See CANNABINOID HYPEREMESIS SYNDROME)
HYSTERECTOMY (See Pre-2000 List)


HAIR
Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15927811
Inhibition of human hair follicle growth by endo and exocannabinoids (full–2007) http://www.fasebj.org/cgi/reprint/21/13/3534?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=cannabis&andorexactfulltext=and&searchid=1&FIRSTINDEX=10&sortspec=relevance&resourcetype=HWCIT
Endocannabinoids enhance lipid synthesis and apoptosis of human sebocytes via cannabinoid receptor-2-mediated signaling (full–2008) http://www.fasebj.org/content/22/10/3685.long
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/
top


HEARING
The acute effects of tetrahydrocannabinol on auditory threshold and frequency resolution in human subjects (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12195931
A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss (full–2003) http://www.jneurosci.org/content/23/24/8596.long
Doctor’s diary: cannabis as medicine – the dilemma (news/forum repost–2005) http://www.420magazine.com/forums/tinnitus/183111-doctor-s-diary-cannabis-medicine-dilemma.html
Cochlear implantation trauma and noise-induced hearing loss: Apoptosis and therapeutic strategies (full-2006) http://onlinelibrary.wiley.com/doi/10.1002/ar.a.20305/pdf
AM-111 reduces hearing loss in a guinea pig model of acute labyrinthitis (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/18322422
Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17712672
Cannabinoid receptor down-regulation in the ventral cochlear nucleus in a salicylate model of tinnitus (abst-2007)  http://www.ncbi.nlm.nih.gov/pubmed/17376618
AM-111 protects against permanent hearing loss from impulse noise trauma (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/16839720
Cannabinoid CB2 receptor expression in the rat brainstem cochlear and vestibular nuclei  (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/19086305
AM-111 prevents hearing loss from semicircular canal injury in otitis media (full–2009) http://onlinelibrary.wiley.com/doi/10.1002/lary.20759/pdf
Blocking pro-cell-death signal pathways to conserve hearing (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19923808


HEART DISEASE / CARDIOVASCULAR
Cardiovascular effects of endocannabinoids – the plot thickens (abst–2000) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=10785543&dopt=abstractplus
Involvement of central and peripheral cannabinoid receptors in the regulation of heart resistance to arrhythmogenic effects of epinephrine (abst–2000) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=11182823&dopt=abstractplus
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction (full-2001) http://content.onlinejacc.org/cgi/content/full/38/7/2048?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=560&resourcetype=HWCIT
Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries (full-2001) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573021/?tool=pmcentrez
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts (full–2001) http://cardiovascres.oxfordjournals.org/content/55/3/619.full?sid=750cba66-d3d1-484d-96e8-04975ba34325
Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors (abst–2001) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=11427912&dopt=abstractplus
top
Influence of the CB1 receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats (full–2002) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573379/?tool=pmcentrez
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts (full–2002) http://cardiovascres.oxfordjournals.org/content/55/3/619.long
Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation (full–2002) http://bloodjournal.hematologylibrary.org/content/100/12/4040.full
Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis (abst–2002) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=12428278&dopt=abstractplus
Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12227101
Increase of the heart arrhythmogenic resistance and decrease of the myocardial necrosis zone during activation of cannabinoid receptors (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12136723
Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism (abst–2002) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=12428277&dopt=abstractplus
The quest for a vascular endothelial cannabinoid receptor (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12505689
Endocannabinoids protect the rat isolated heart against ischaemia (full–2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573907/?tool=pmcentrez
Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery (full-2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573773/?tool=pmcentrez
CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction (full-2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573770/?tool=pmcentrez
Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN (full–2003) http://www.jleukbio.org/cgi/content/full/75/3/453?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT
A new endothelial target for cannabinoids (full–2003) http://molpharm.aspetjournals.org/content/63/3/469.long
Endocannabinoids as mediators in the heart: a potential target for therapy of remodelling after myocardial infarction? (full–2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1573769/?tool=pmcentrez
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor (full–2003) http://molpharm.aspetjournals.org/content/63/3/699.long
Cannabinoids prevented the development of heart failure in animal study (news–2003) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=145#2
Cardiovascular Effects of Cannabis (news-2003) http://www.idmu.co.uk/canncardio.htm
Marijuana Smoking Doesn’t Kill (news–2003) http://www.webmd.com/smoking-cessation/news/20030918/marijuana-smoking-doesnt-kill
Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2756479/?tool=pmcentrez
top
The complexities of the cardiovascular actions of cannabinoids (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574918/?tool=pmcentrez
Characterisation of the vasorelaxant properties of the novel endocannabinoid Narachidonoyl-dopamine (NADA) (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574254/
Heterogeneity in the mechanisms of vasorelaxation to anandamide in resistance and conduit rat mesenteric arteries (full–2004) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1574972/
Vasorelaxant activities of the putative endocannabinoid virodhamine in rat isolated small mesenteric artery (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15233865
Cardiovascular Pharmacology of Cannabinoids (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2228270/?tool=pmcentrez
Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia–reperfusion by a novel cannabinoid mechanism (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1751211/?tool=pmcentrez
Effects of AM281, a cannabinoid antagonist, on systemic haemodynamics, internal carotid artery blood flow and mortality in septic shock in rats (full–2005) http://bja.oxfordjournals.org/content/94/5/563.full
The cardiovascular actions of anandamide: more targets? (full–2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1576182/?tool=pmcentrez
Increased anandamide induced relaxation in mesenteric arteries of cirrhotic rats: role of cannabinoid and vanilloid receptors (full–2005) http://gut.bmj.com/content/54/4/522.full?sid=0731f0e5-2071-4549-be57-57f444307138
Cardiac and vascular effects of cannabinoids: toward a therapeutic use? (abst–2005) http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Retrieve&list_uids=15828464&dopt=abstractplus
Influence of Anandamide, the Endogenous Agonist of Cannabinoid Receptors on the Circulatory System (abst-2005) http://www.ncbi.nlm.nih.gov/pubmed/15928605
Direct cerebrovascular effects of CB1 receptor activation by the synthetic endocannabinoid HU-210 in vivo (abst–2005) http://www.nature.com/jcbfm/journal/v25/n1s/full/9591524.0581a.html
Marijuana Chemical Fights Hardened Arteries (news–2005) http://www.webmd.com/heart-disease/news/20050406/marijuana-chemical-fights-hardened-arteries
Medical marijuana: study shows that THC slows atherosclerosis (news–2005) http://thenexthurrah.typepad.com/the_next_hurrah/2005/04/medical_marijua.html
Cannabis chemical ‘helps heart’ (news-2005) http://news.bbc.co.uk/2/hi/health/4417261.stm
Further Characterization of the Time-Dependent Vascular Effects of Δ9-Tetrahydrocannabinol (full-2006) http://jpet.aspetjournals.org/content/317/1/428.full
Illicit Drug Use in Young Adults and Subsequent Decline in General Health: The Coronary Artery Risk Development in Young Adults (CARDIA) Study (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1885466/?tool=pmcentrez
Signaling pathways involved in the cardioprotective effects of cannabinoids (full-2006) https://www.jstage.jst.go.jp/article/jphs/102/2/102_2_155/_pdf
Does Cannabis Hold the Key to Treating Cardiometabolic Disease (full–2006) http://www.nature.com/nrcardio/journal/v3/n3/full/ncpcardio0504.html
top
N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413724/
Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor (full–2006) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1616976/
US Patent 7109245 – Vasoconstrictor cannabinoid analogs (full–2006) http://www.freepatentsonline.com/7109245.html
The endogenous cardiac cannabinoid system: a new protective mechanism against myocardial ischemia (abst-2006) http://www.ncbi.nlm.nih.gov/pubmed/16618028
Delta-9-tetrahydrocannabinol protects cardiac cells from hypoxia via CB2 receptor activation and nitric oxide production (abst–2006) http://www.ingentaconnect.com/content/klu/mcbi/2006/00000283/F0020001/00002346
Marijuana use, diet, body mass index, and cardiovascular risk factors (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16893701
Cannabis use not associated with risk factors for diseases of heart and circulation (news–2006) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=225#2
THC protects heart cells in the case of lowered oxygen supply (news–2006) http://www.cannabis-med.org/english/bulletin/ww_en_db_cannabis_artikel.php?id=212#1
Cannabinoid Offers Cardioprotection (news–2006) http://www.norml.org/index.cfm?Group_ID=6818&wtm_format=print
Heavy Cannabis Use Not Independently Associated With Cardiovascular Risks (news-2006) http://www.norml.org/index.cfm?Group_ID=6972
The in vitro and in vivo cardiovascular effects of {Delta}9-tetrahydrocannabinol (THC) in rats made hypertensive by chronic inhibition of nitric oxide synthase (full–2007) http://jpet.aspetjournals.org/content/321/2/663.full
Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190007/?tool=pubmed
The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190033/?tool=pubmed
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225474/?tool=pmcentrez
Endocannabinoids and the haematological system (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190025/?tool=pmcentrez
Cannabinoids and cardiovascular disease: a tale of passions and illusions (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2013961/?tool=pubmed
Cardiovascular Abnormalities in Cirrhosis: the Possible Mechanisms (full–2007) http://journals.tums.ac.ir/upload_files/pdf/_/6670.pdf
Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusions (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2013961/pdf/0707261a.pdf
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2225473/?tool=pubmed
GPR55 and the vascular receptors for cannabinoids (full–2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190021/?tool=pubmed
Cannabidiol, a nonpsychoactive Cannabis constituent, protects against myocardial ischemic reperfusion injury (full–2007) http://ajpheart.physiology.org/cgi/content/full/293/6/H3602
Cardiovascular effects of cannabinoids in conscious spontaneously hypertensive rats (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190006/?tool=pmcentrez
top
Effect of dietary hempseed intake on cardiac ischemia-reperfusion injury (full–2007) http://ajpregu.physiology.org/content/292/3/R1198.long
Cannabinoids and cardiovascular disease: the outlook for clinical treatments (abst–2007) http://www.ncbi.nlm.nih.gov/pubmed/17627561?ordinalpos=1&itool=PPMCLayout.PPMCAppController.PPMCArticlePage.PPMCPubmedRA&linkpos=5
Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/17921818
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219532/
Cannabinoid receptors in acute and chronic complications of atherosclerosis (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219535/?tool=pmcentrez
Role of endocannabinoids in cardiovascular shock (full-2008) http://www.jpp.krakow.pl/journal/archive/12_08_s8/pdf/91_12_08_s8_article.pdf
Endocannabinoids and Liver Disease. V. Endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis (full–2008) http://ajpgi.physiology.org/content/295/4/G649.full?sid=c16d770d-cd17-48c9-bbde-26f38f5eeb67
CB1 Cannabinoid Receptor Inhibition: Promising Approach for Heart Failure? (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669829/?tool=pmcentrez
‘Entourage’ effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2597234/?tool=pubmed
Modulation of the Endocannabinoid System in Cardiovascular Disease (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568884/?tool=pmcentrez
Acute hypertension reveals depressor and vasodilator effects of cannabinoids in conscious rats (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697765/?tool=pmcentrez
Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioning (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219536/?tool=pmcentrez
Virodhamine relaxes the human pulmonary artery through the endothelial cannabinoid receptor and indirectly through a COX product (full-2008) http://www.ncbi.nlm.nih.gov/pubmed/18806815
Endocannabinoids, blood pressure and the human heart (full-2008) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2826.2008.01677.x/full
The endocannabinoid system: an osteopathic perspective (full-2008) http://www.jaoa.org/cgi/content/full/108/10/586
Function of cannabinoids in heart failure (link to full-2008) http://www.unboundmedicine.com/medline/citation/18464680/abstract/%5BFunction_of_cannabinoids_in_heart_failure%5D
Dexanabinol prevents development of vasospasm in the rat femoral artery model (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18256864
Endocannabinoids and cardiac contractile function: pathophysiological implications (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768548/?tool=pubmed
Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner (full-2009) http://cardiovascres.oxfordjournals.org/content/85/1/56.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Endocannabinoids and the Heart (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2728560/?tool=pmcentrez
The emerging role of the endocannabinoid system in cardiovascular disease (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791499/?tool=pmcentrez
top
Endocannabinoid signalling as an anti-inflammatory therapeutic target in atherosclerosis: does it work? (full-2009) http://cardiovascres.oxfordjournals.org/content/84/3/341.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages (full-2009) http://cardiovascres.oxfordjournals.org/content/84/3/378.full?sid=7d2438c4-a727-410f-870d-4a971695b4fb
Cannabidiol Attenuates Myocardial Dysfunction, Fibrosis, Inflammation, Cell Death and Interrelated Signaling Pathways Associated With Diabetic Cardiomyopathy (full- 2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026637/
Processing cardiovascular information in the vlPAG during electroacupuncture in rats: roles of endocannabinoids and GABA (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2692771/#!po=4.54545 Endocannabinoids and cardiovascular prevention: real progress? (link to PDF-2009) http://www.pagepress.org/journals/index.php/hi/article/view/1162
Time-dependent vascular actions of cannabidiol in the rat aorta (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19285060
CB2 cannabinoid receptor activation is cardioprotective in a mouse model of ischemia / reperfusion (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19162037
Cannabinoids and atherosclerosis (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19591373?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=13


HEMOPHILIA
Medical Marijuana and Hemophilia A (news–2009) https://www.marijuanadoctors.com/content/ailments/view/34?ailment=hemophilia-a


HEMORRHAGIC SHOCK
Endocannabinoids and cardiac contractile function: pathophysiological implications (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768548/?tool=pubmed


HEMP
Industrial Hemp in the United States: Status and Market Potential (full-2000) http://www.ers.usda.gov/media/328262/ages001e_1_.pdf
Variations of D9-THC content in single plants of hemp varieties (full-2000) http://www.ukcia.org/research/VariationOfTHCContent.pdf
GC-MS analysis of the total delta9-THC content of both drug- and fiber-type cannabis seeds (full–2000) http://jat.oxfordjournals.org/content/24/8/715.long
Consumption and quantitation of delta9-tetrahydrocannabinol in commercially available hemp seed oil products (full–2000) http://jat.oxfordjournals.org/content/24/7/562.long
New Tropical Industrial Hemp (full–2001) http://www.hempreport.com/issues/17/australia16.html
Evaluating the impact of hemp food consumption on workplace drug tests (full–2001) http://jat.oxfordjournals.org/content/25/8/691.long
Industrial Hemp (Cannabis sativa L.) as a Papermaking Raw Material in Minnesota: Technical, Economic, and Environmental Considerations (full–2001) http://www.votehemp.com/PDF/hemp.pdf
Cannabis: an environmentally and economically viable method for climate change mitigation (revised 2001) (thesis–2001) http://www.hempreport.com/issues/17/pdf/deeleythesis.pdf
top
Industrial Hemp Makes Sense For Us (article–2001) http://www.ratical.org/renewables/JoeAmericanHorse.html
Remediation of benzo[a]pyrene and chrysene-contaminated soil with industrial hemp (Cannabis sativa) (abst–2002) http://www.ncbi.nlm.nih.gov/pubmed/12655808
This Bud’s Not For You (news–2002) http://content.time.com/time/magazine/article/0,9171,201911,00.html
Hemp: A New Crop with New Uses for North America (news–2002) http://www.hort.purdue.edu/newcrop/ncnu02/v5-284.html
Nutritional Profile and Benefits of Hemp Seed, Nut, and Oil (article-2003) http://www.healthbeyondhype.com/info/nutritional-profile-and-benefits-of-hemp-seed-nut-and-oil
A biological oil adsorption filter (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/15556187
Determination of cannabinoids in hemp food products by use of headspace solid-phase microextraction and gas chromatography-mass spectrometry (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14598006
Cover Me with Hemp (news–2004) http://www.nrc-cnrc.gc.ca/eng/achievements/highlights/2004/hemp.html
Ford And Deisel Never Intended Cars To Use Gasoline (news–2005) http://www.rense.com/general67/FORD.HTM
Genetic Variation in Hemp and Marijuana (Cannabis sativa L.) According to Amplified Fragment Length Polymorphisms (full–2006) http://geo.cbs.umn.edu/Datwyler&Weiblen2006.pdf
Nova Scotia: A Maritime Industrial Hemp Product Marketing Study (full–2006) http://www.votehemp.com/PDF/MaritimeHemp.pdf
DNA poly morphisms in the tetrahydrocannabinolic acid (THCA) synthase gene in “drug-type” and “fiber-type” Cannabis sativa L (abst–2006) http://www.ncbi.nlm.nih.gov/pubmed/16143478
THE EFFECT OF PLANT DENSITY AND NITROGEN FERTILIZER ON LIGHT INTERCEPTION AND DRY MATTER YIELD IN HEMP (CANNABIS SATIVA L.) (abst-2006) http://en.journals.sid.ir/ViewPaper.aspx?ID=102781
Analytical characterization of hemp (Cannabis sativa ) seed oil from different agroecological zones of Pakistan (abst–2006) http://link.springer.com/article/10.1007%2Fs11746-006-1207-x
DEA spends big $$$ to eradicate feral hemp (news–2006) http://tribes.tribe.net/time_4_hemp/thread/6bf51037-3518-47aa-aeab-e28da81e9446
Apparent increase in biomass and see productivity in hemp (Cannabis sativa) resulting from branch proliferation caused by the European corn borer (Ostrinia nubilalis) (abst–2007) http://www.agr.gc.ca/eng/abstract/?id=9561000000564
Cosmetic Manufacturers Harness the Power of Hemp (news–2007) http://www.cosmeticsdesign.com/Formulation-Science/Cosmetic-manufacturers-harness-the-power-ofHemp
Detection method for the ability of hemp (Cannabis sativa L.) seed germination by the use of 2,3,5-triphenyl-2H-tetrazolium chloride (TTC) (full-2008) https://www.jstage.jst.go.jp/article/yakushi/128/11/128_11_1707/_pdf
Characterization of Medicinal Properties of Cannabis sativa L. Roots (full-2008) http://archives.hempembassy.net/hempe/resources/blairvanpeltcannabisroot%20_NXPowerLite_.pdf
Photosynthetic response of Cannabis sativa L. to variations in photosynthetic photon flux densities, temperature and CO2 conditions (full-2008)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550641/
EFFECT OF GERMINATION ON HEMP (CANNABIS SATIVA L.) SEED COMPOSITION (full-2008) http://saiapm.ulbsibiu.ro/rom/cercetare/ACTA_E/AUCFT%202008II%2027_34.pdf
Hemp Ethanol Saves the World (1) – The Economics of Hemp Fuels (article-2008) http://hemp-ethanol.blogspot.com/2008/01/economics-history-and-politics-of-hemp.html
top
Hemp Ethanol Saves the World (2) – The History of Hemp Fuels (article–2008) http://hemp-ethanol.blogspot.com/2008/01/part-two-history-of-hemp-fuels.html
Hemp Ethanol Saves the World (3) – The Politics of Hemp Fuels (article–2008) http://hemp-ethanol.blogspot.com/2008/01/part-three-politics-of-hemp-fuels.html
Essential fatty acids, nutritive value and oxidative stability of cold pressed hempseed (Cannabis sativa L.) oil from different varieties (1st page–2008) http://www.akademiai.com/doi/abs/10.1556/AAlim.2008.0035
Virgin hemp seed oil: An interesting niche product (abst–2008) http://onlinelibrary.wiley.com/doi/10.1002/ejlt.200700311/abstract;jsessionid=3D837473A3139F03ECE86C45085E4B8F.f01t04
Seawater-retting treatment of hemp and characterization of bacterial strains involved in the retting process (abst–2008)
http://www.sciencedirect.com/science/article/pii/S1359511308002006
Influence of the Growth Stage of Hemp (Cannabis sativa L.) on Fatty Acid Content, Chemical Composition and Gross Energy (full–2009) http://www.medwelljournals.com/fulltext/?doi=aj.2009.27.31
Characterization and antimicrobial activity of essential oils of industrial hemp varieties (Cannabis sativa L.) (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19969046
Hemp: A replacement for common food allergens? (news-2009) http://thefoodallergycoach.blogspot.com/2009/05/hemp-replacement-for-common-food.html
Hemp Cleans Up in Chernobyl (news–2009) http://web.archive.org/web/20090718104711/http://pr.cannazine.co.uk/200907101115/green/eco news/hemp-cleans-up-in-chernobyl.html


HEPATITIS
A Novel Synthetic Cannabinoid Derivative Inhibits Inflammatory Liver Damage via Negative Cytokine Regulation (full–2003) http://molpharm.aspetjournals.org/content/64/6/1334.full
The endocannabinoid system in chronic liver disease (full–2005) http://www.medigraphic.com/pdfs/hepato/ah-2005/ah054c.pdf
(Marijuana/Hash) Endocannabinoids and liver disease – review (full–2005) http://www.natap.org/2005/HCV/091905_01.htm
Antifibrogenic role of the cannabinoid receptor CB2 in the liver (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/15765409
Cannabis use improves retention and virological outcomes in patients treated for hepatitis C (full-2006) http://www.natap.org/2006/HCV/091506_02.htm
Study: Pot Helps Hepatitis Treatment (news–2006) http://www.thehempire.com/index.php/cannabis/news/study_pot_helps_hepatitis_treatment
Endocannabinoids and Liver Disease. III. Endocannabinoid effects on immune cells: implications for inflammatory liver diseases (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376822/?tool=pmcentrez
Attenuation of Experimental Autoimmune Hepatitis by Exogenous and Endogenous Cannabinoids : Involvement of Regulatory T Cells (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828293/?tool=pmcentrez
Evaluation of oral cannabinoid-containing medications for the management of interferon and ribavirin-induced anorexia, nausea and weight loss in patients treated for chronic hepatitis C virus (full–2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2662895/?tool=pmcentrez
top
Regression of Fibrosis after Chronic Stimulation of Cannabinoid CB2 Receptor in Cirrhotic Rats (full–2008) http://jpet.aspetjournals.org/content/324/2/475.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=320&resourcetype=HWCIT#content-block
Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects (abst-2008) http://gut.bmj.com/content/57/8/1140.abstract
Endocannabinoids in liver disease and hepatic encephalopathy (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18781986
Should Hepatitis C Patients Who Smoke Marijuana Be Eligible For Liver Transplants? (news-2008) http://www.sciencedaily.com/releases/2008/10/081022211032.htm
Cannabinoids as novel anti-inflammatory drugs (full–2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/?tool=pubmed
US Patent Application 20090005461 – Use of Cannabidiol in the Treatment of Hepatitis (full–2009) http://www.google.com/patents/US20120302646
The role of CB2 cannabinoid receptor and Leptin in hepatic fibrosis via lymphocyte alterations and HSC phagocytosis (abst–2009) http://www.docstoc.com/docs/76792678/The-role-of-CB2-cannabinoid-receptor-and-Leptin-in-hepatic
Use of Cannabinoids as a Novel Therapeutic Modality Against Autoimmune Hepatitis (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19647124
Medical Marijuana and Hepatitis C (news–2009) https://www.marijuanadoctors.com/content/ailments/view/75?ailment=hepatitis-c-
Medical Marijuana and Viral Hepatitis (news–2009) https://www.marijuanadoctors.com/content/ailments/view/70?ailment=viral-hepatitis


HEREDITARY MULTIPLE EXOTOSES
Chronic Cannabis Use in the Compassionate Investigational New Drug Program: An Examination of Benefits and Adverse Effects of Legal Clinical Cannabis (full–2002) http://proxy.baremetal.com/cannabiscoalition.ca/chronic.pdf
Chronic Cannabis Use in the Compassionate Investigational New Drug Program (abstract & comments-2002) http://www.letfreedomgrow.com/cmu/chronic_cannabis_use.htm


HERPES VIRUS
THC inhibits lytic replication of gamma oncogenic herpes viruses in vitro (full-2004) http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=521080
Cannabis May Help Combat Cancer-causing Herpes Viruses (news-2004) http://www.sciencedaily.com/releases/2004/09/040923092627.htm
THC in marijuana may block the spread of forms of cancer causing herpes viruses (news-2004) http://www.news-medical.net/news/2004/09/22/4990.aspx
Treatment of Refractory Post Herpetic Neuralgia with Nabilone (abst–2009) http://www.efic-congress.org/showabstract.php?abstract=699


HICCUPS
Hiccups by Ben (anecdotal–undated) http://rxmarijuana.com/shared_comments/hiccups.htm
Cannabinoids suppress synaptic input to neurones of the rat dorsal motor nucleus of the vagus nerve (full–2004) http://jp.physoc.org/content/559/3/923.full#sec-19
top


HIP REPLACEMENT
Endogenous cannabinoids are candidates for lipid mediators of bone cement implantation syndrome (abst–2004) http://www.ncbi.nlm.nih.gov/pubmed/14676677


HIV / AIDS
Therapeutic Aspects of Cannabis and Cannabinoids (full-2001) http://bjp.rcpsych.org/cgi/reprint/178/2/107.pdf
Short-term effects of cannabinoids in patients with HIV-1 infection (full-2003) http://www.420magazine.com/forums/hiv-aids-human-immunodeficiency-virus/161873-short-term-effectscannabinoids-patients-hiv-1-infection.html
US Patent 6630507 – Cannabinoids as antioxidants and neuroprotectants (full-2003) (Assignee [owner] – the US GOVERNMENT!) http://www.google.com/patents/US6630507
Cannabis and the brain (full-2003) http://brain.oxfordjournals.org/cgi/content/full/126/6/1252
Therapeutic potential of cannabinoids in CNS disease (abst-2003) http://www.ncbi.nlm.nih.gov/pubmed/12617697
Cannabis Use in HIV for Pain and Other Medical Symptoms (full-2004) http://www.jpsmjournal.com/article/S0885-3924(05)00063-1/fulltext
Marijuana Use Does Not Accelerate HIV Infection (news-2004) http://paktribune.com/news/print.php?id=139255
Mechanisms of HIV-1 inhibition by the lipid mediator N-arachidonoyldopamine (full–2005) http://www.jimmunol.org/content/175/6/3990.long
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation (link to PDF-2005) http://www.springerlink.com/content/tq777102q4185073/fulltext.html
Smoked cannabis therapy for HIV-related painful peripheral neuropathy (abst-2005) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=172
Cannabis: Use in HIV for Pain and Other Medical Symptoms (abst-2005) http://www.ncbi.nlm.nih.gov/pubmed/15857739
The endocannabinoid system in targeting inflammatory neurodegenerative diseases (full-2007) http://www.academia.edu/5172933/The_endocannabinoid_system_in_targeting_inflammatory_neurodegenerative_diseases
THC improves appetite and reverses weight loss in AIDS patients (abst-2007) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=189
Dronabinol and marijuana in HIV-positive marijuana smokers: caloric intake, mood, and sleep (abst-2007) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=190
Cannabis in painful HIV-associated sensory neuropathy (abst-2007) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=199
Marijuana as therapy for people living with HIV/AIDS: Social and health aspects (abst-2007) http://www.unboundmedicine.com/medline/ebm/record/17364413/abstract/Marijuana_as_therapy_for_people_living_with_HIV/AIDS:_Social_and_health_aspects
Cannabis may be safe and effective for HIV-related neuropathic pain (news-2007) http://www.aidsmap.com/en/news/E0578F66-B327-4504-836D-DEE790B87A0F.asp
Smoked Cannabis Reduces Foot Pain Associated With HIV In Placebo Trial (news-2007) http://www.sciencedaily.com/releases/2007/02/070212185335.htm
top
Marijuana gives relief from chronic pain for AIDS sufferers (news – 2007) http://www.news-medical.net/news/2007/02/14/21906.aspx
Recreational Drug Use and T Lymphocyte Subpopulations in HIV-uninfected and HIVinfected Men (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2691391/?tool=pmcentrez
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial (full-2008) http://www.nature.com/npp/journal/v34/n3/abs/npp2008120a.html
Cannabinoid CB2 receptors in human brain inflammation (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2219537/
Cannabinoids Inhibit HIV-1 Gp120-Mediated Insults in Brain Microvascular Endothelial Cells (full-2008) http://www.jimmunol.org/cgi/content/full/181/9/6406?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=160&resourcetype=HWCIT
Denbinobin, a naturally occurring 1,4-phenanthrenequinone, inhibits HIV-1 replication through an NF-kappaB-dependent pathway (abst-2008) http://marijuana.researchtoday.net/archive/5/10/2003.htm
Weeding out the highs of medical marijuana (news–2008) http://www.alphagalileo.org/ViewItem.aspx?ItemId=4726&CultureCode=en
Marijuana Effectiveness as an HIV Self-Care Strategy (abst-2009) http://cnr.sagepub.com/cgi/content/abstract/18/2/172
Recreational Drug Use and Risk of Kaposi’s Sarcoma in HIV- and HHV-8-Coinfected Homosexual Men (abst-2009) http://www.liebertonline.com/doi/abs/10.1089/aid.2008.0196?prevSearch=allfield%253A%2528cannabinoid%2529&searchHistoryKey=
Marijuana Rivals Mainstream Drugs For Alleviating HIV/AIDS Symptoms (news-2009) http://www.sciencedaily.com/releases/2009/05/090529081627.htm
Medical Marijuana and AIDS Related Illness (news–2009) https://www.marijuanadoctors.com/content/ailments/view/4?ailment=aids-related-illness


HOMEOSTASIS
The cannabinoid system: a role in both the homeostatic and hedonic control of eating? (full–2003) http://www.nutritionsociety.org.uk/bjn/090/0729/0900729.pdf
The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis (full-2003) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC166293/
The Ffa Receptor Gpr40 Links Hyperinsulinemia, Hepatic Steatosis, and Impaired Glucose Homeostasis in Mouse (full–2005) http://www.sciencedirect.com/science/article/pii/S1550413105000860
Endocannabinoids: Multi-scaled, Global Homeostatic Regulators of Cells and Society (full-2006) http://www.necsi.edu/events/iccs6/papers/0f3785aa40623a5a781701618c4e.pdf
The emerging role of the endocannabinoid system in endocrine regulation and energy balance (full-2006) http://press.endocrine.org/doi/full/10.1210/er.2005-0009
Role of cannabinoid CB2 receptors in glucose homeostasis in rats (abst–2007) http://www.sciencedirect.com/science/article/pii/S001429990700249X
Endocannabinoids and the Control of Energy Homeostasis (full-2008) http://www.jbc.org/content/283/48/33021.full?sid=931583b1-e797-43e0-8296-7fd75bb49403
top
The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation (full-2009) http://www.nature.com/ijo/journal/v33/n2s/full/ijo200967a.html
Sex differences in the cannabinoid regulation of energy homeostasis (abst-2009) http://www.psyneuen-journal.com/article/S0306-4530%2809%2900123-1/abstract


HORMONES
Nutrition for Moms-to-be! (article-undated) http://manitobaharvest.com/articles_studies/3812/Hemp-Packs-in-Powerful-Source-of-Preconception-Nutrition.html
Hemp = Hormonal Balance (ad/article-undated) http://manitobaharvest.com/articles_studies/3815/Women-Find-Healthy-Hormone-Balance-with-Hemp.html
Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland (abst–2000) http://www.ncbi.nlm.nih.gov/pubmed/10733937
Normal Human Pituitary Gland and Pituitary Adenomas Express Cannabinoid Receptor Type 1 and Synthesize Endogenous Cannabinoids: First Evidence for a Direct Role of Cannabinoids on Hormone Modulation at the Human Pituitary Level (full-2001) http://press.endocrine.org/doi/full/10.1210/jcem.86.6.7565?view=long&pmid=11397872
How might cannabinoids influence sexual behavior? (full-2001) http://www.pnas.org/content/98/3/793.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=880&resourcetype=HWCIT
Dysregulated Cannabinoid Signaling Disrupts Uterine Receptivity for Embryo Implantation (full-2001) http://www.jbc.org/content/276/23/20523.full?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid+estrogen&searchid=1&FIRSTINDEX=0&resourcetype=HWCIT
Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters (abst-2001) http://www.ncbi.nlm.nih.gov/pubmed/11566149
The Central Cannabinoid Receptor Inactivation Suppresses Endocrine Reproductive Functions (abst–2001) http://www.ncbi.nlm.nih.gov/pubmed/11394887
Sex Differences in Antinociceptive and Motoric Effects of Cannabinoids (abst-2001) http://www.ncbi.nlm.nih.gov/pubmed/11698061
Endocrine Effects of Marijuana (full–2002) http://ukcia.org/research/EndocrineEffects.pdf
Estrogen stimulates arachidonoylethanolamide release from human endothelial cells and platelet activation (full-2002) http://bloodjournal.hematologylibrary.org/content/100/12/4040.full
The endogenous cannabinoid, anandamide, activates the hypothalamo-pituitary-adrenal axis in CB1 cannabinoid receptor knockout mice (abst-2003) http://www.ncbi.nlm.nih.gov/pubmed/14688442?dopt=Abstract
Cannabinoid receptor type 1 (CB1) affects hypothalamic-pituitary-adrenal (HPA) axis activity at cerebral and pituitary level (abst-2003) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-2003-817562
Endogenous Cannabinoids Take the Edge off Neuroendocrine Responses to Stress (full-2004) http://press.endocrine.org/doi/full/10.1210/en.2004-1218
Regulation of Gonadotropin-Releasing Hormone Secretion by Cannabinoids (full-2005) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1237039/?tool=pmcentrez
top
Effects of cannabinoids on hypothalamic and reproductive function (abst–2005) http://www.ncbi.nlm.nih.gov/pubmed/16596787?dopt=AbstractPlus
Jekyll and Hyde: Two Faces of Cannabinoid Signaling in Male and Female Fertility (full-2006) http://press.endocrine.org/doi/full/10.1210/er.2006-0006
The emerging role of the endocannabinoid system in endocrine regulation and energy balance (full-2006) http://press.endocrine.org/doi/full/10.1210/er.2005-0009
Cannabinoids attenuate norepinephrine-induced melatonin biosynthesis in the rat pineal gland by reducing arylalkylamine N-acetyltransferase activity without involvement of cannabinoid receptors (full–2006) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2006.03873.x/pdf
The impact of obesity on reproduction in women with polycystic ovary syndrome (full-2006) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-0528.2006.00990.x/pdf
Cannabis reward: biased towards the fairer sex? (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190004/
Cannabinoid self-administration in rats: sex differences and the influence of ovarian function (full-2007) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190022/
The rat pineal gland comprises an endocannabinoid system (abst–2008) http://www.ncbi.nlm.nih.gov/pubmed/18554250
Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/1893877
Localisation and Function of the Endocannabinoid System in the Human Ovary (full-2009) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2640464/?toolmcentrez
Fluctuation in anandamide levels from ovulation to early pregnancy in in-vitro fertilization-embryo transfer women, and its hormonal regulation (full-2009) http/humrep.oxfordjournals.org/content/24/8/1989.long
The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities (full-2009) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2757311/
Type 1 Cannabinoid Receptor-Containing Axons Innervate Hypophysiotropic Thyrotropin-Releasing Hormone-Synthesizing Neurons (full-2009) http/endo.endojournals.org/content/150/1/98.full?sid=f5b14012-9fbe-4f10-890c-386313060cf8
Male-female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function (abst-2009) http/www.ncbi.nlm.nih.gov/pubmed/19733173
Medical Marijuana and Premenstrual Syndrome (PMS) (news–2009) https/www.marijuanadoctors.com/content/ailments/view/156?ailmentremenstrual-syndrome-pms-


HPV / HUMAN PAPILLOMA VIRUS
Marijuana use and cervical HPV/neoplasia (abst-2008) http://www.infectagentscancer.com/content/4/S2/P15
Bogarting that joint might decrease oral hpv among cannabis users (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2794675/?tool=pubmed
top


HUNTINGTON’S DISEASE
Cannabinoid Receptor Messenger Rna Levels Decrease in a Subset of Neurons of the Lateral Striatum, Cortex and Hippocampus of Transgenic Huntington’s Disease Mice (abst-2000) http://www.ncbi.nlm.nih.gov/pubmed/10891614
Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington’s disease (abst-2001) http://www.ncbi.nlm.nih.gov/pubmed/11447320
Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington’s disease (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/11842443
Loss of cannabinoid CB(1) receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington’s disease (abst-2002) http://www.ncbi.nlm.nih.gov/pubmed/12709298
Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington’s disease (abst-2003) http://www.ncbi.nlm.nih.gov/pubmed/12603833
Effects of cannabinoids in the rat model of Huntington’s disease generated by an intrastriatal injection of malonate (abst-2003) http://www.ncbi.nlm.nih.gov/pubmed/12858038
The endocannabinoid system and Huntington’s disease (abst-2003) http://www.ncbi.nlm.nih.gov/pubmed/14529364
Structure, expression and regulation of the cannabinoid receptor gene (CB1) in Huntington’s disease transgenic mice (full-2004) http://onlinelibrary.wiley.com/doi/10.1111/j.1432-1033.2004.04460.x/full
Delayed onset of Huntington’s disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors (abst-2004) http://www.ncbi.nlm.nih.gov/pubmed/14667455
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo (abst-2004)http://www.ncbi.nlm.nih.gov/pubmed/15640759
Cannabinoid control of motor function at the basal ganglia (abst-2005) http://www.ncbi.nlm.nih.gov/pubmed/16596785
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington’s disease mice (abst-2005) http://www.ncbi.nlm.nih.gov/pubmed/15953496
Nabilone Could Treat Chorea and Irritability in Huntington’s Disease (letter-2006) http://neuro.psychiatryonline.org/article.aspx?articleid=102920
UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington’s disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders (abst–2006)http://www.ncbi.nlm.nih.gov/pubmed/16006105
Cannabinoids and neuroprotection in motor-related disorders (abst-2007) http://www.ncbi.nlm.nih.gov/pubmed/18220777
Altered Lipid Metabolism in Brain Injury and Disorders (full-2008) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2293298/?tool=pmcentrez
The endocannabinoid system in Huntington’s disease (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18781982
The endocannabinoid pathway in Huntington’s disease: a comparison with other neurodegenerative diseases (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/17276576
Role of CB2 receptors in neuroprotective effects of cannabinoids (abst-2008) http://www.ncbi.nlm.nih.gov/pubmed/18291574
The endocannabinoid system as a target for the treatment of motor dysfunction (full-2009) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697699/
top
Microglial CB2 cannabinoid receptors are neuroprotective in Huntington’s disease excitotoxicity (full-2009) http://brain.oxfordjournals.org/content/132/11/3152.long
Altered CB1 receptor and endocannabinoid levels precede motor symptom onset in a transgenic mouse model of Huntington’s disease (abst–2009) http://www.ncbi.nlm.nih.gov/pubmed/19524019
A pilot study using nabilone for symptomatic treatment in Huntington’s disease (abst-2009) http://www.unboundmedicine.com/medline/ebm/record/19845035/abstract/A_pilot_study_using_nabilone_for_symptomatic_treatment_in_Huntington%27s_disease_
Cannabinoids and neurodegenerative diseases (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19839933
Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington’s disease (abst-2009) http://www.ncbi.nlm.nih.gov/pubmed/19115380
Medical Marijuana and Huntington’s Disease (news-2009) https://www.marijuanadoctors.com/content/ailments/view/143?ailment=huntington-s-disease